- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 213/75 - Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Patent holdings for IPC class C07D 213/75
Total number of patents in this class: 1418
10-year publication summary
110
|
125
|
97
|
103
|
95
|
102
|
83
|
86
|
61
|
21
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Vertex Pharmaceuticals Incorporated | 1581 |
36 |
Novartis AG | 11238 |
28 |
Bristol-myers Squibb Company | 5080 |
28 |
Cytokinetics, Inc. | 259 |
27 |
BASF SE | 19740 |
19 |
Nippon Soda Co., Ltd. | 890 |
19 |
Boehringer Ingelheim International GmbH | 4629 |
17 |
Syngenta Participations AG | 4970 |
17 |
F. Hoffmann-La Roche AG | 7958 |
16 |
Genentech, Inc. | 3742 |
14 |
Amgen Inc. | 3779 |
14 |
Takeda Pharmaceutical Company Limited | 2961 |
14 |
Corteva Agriscience LLC | 2494 |
14 |
Sanofi | 3836 |
13 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 762 |
12 |
Mitsui Chemicals Crop & Life Solutions,Inc. | 142 |
12 |
Sumitomo Chemical Company, Limited | 8808 |
10 |
Lead Pharma Holding B.V. | 27 |
10 |
ADT Pharmaceuticals, LLC | 14 |
10 |
AstraZeneca AB | 3042 |
9 |
Other owners | 1079 |